TAZAROTENE

TAZAROTENE was reported 1186 times

TAZAROTENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWEAT GLAND EXCISION 3 0.1304
1 HYPERTROPHIC ANAL PAPILLA 1 0.0417
2 NAIL CANDIDA 1 0.0417
3 POIKILODERMA 3 0.0278
4 DOUBLE URETER 1 0.0250
5 CARDIAC IMAGING PROCEDURE ABNORMAL 1 0.0238
6 POST INFLAMMATORY PIGMENTATION CHANGE 9 0.0199
7 BENIGN FAMILIAL PEMPHIGUS 1 0.0154
8 BASOPHILIA 1 0.0133
9 BREAST PROSTHESIS REMOVAL 1 0.0123
10 EPIDERMODYSPLASIA VERRUCIFORMIS 2 0.0119
11 BIOPSY BREAST ABNORMAL 1 0.0105
12 BIOPSY LYMPH GLAND 1 0.0102
13 LENTIGO 5 0.0101
14 FEMORAL HERNIA 1 0.0093
15 IMPLANT SITE HYPERSENSITIVITY 1 0.0090
16 CHOROID MELANOMA 1 0.0088
17 FIBROUS HISTIOCYTOMA 3 0.0085
18 APPLICATION SITE HYPOAESTHESIA 2 0.0085
19 FONTANELLE BULGING 1 0.0085
20 ANAESTHESIA 3 0.0082
21 SKIN DEPIGMENTATION 11 0.0081
22 MYOCARDIAL STRAIN 1 0.0072
23 BURNS FIRST DEGREE 2 0.0070
24 APLASIA CUTIS CONGENITA 1 0.0070
25 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
26 IMMUNOLOGY TEST ABNORMAL 1 0.0064
27 EYE PARAESTHESIA 1 0.0064
28 BLOOD IMMUNOGLOBULIN E DECREASED 1 0.0062
29 LATENT AUTOIMMUNE DIABETES IN ADULTS 1 0.0058
30 PERIORBITAL IRRITATION 2 0.0058
31 APPLICATION SITE EXFOLIATION 24 0.0058
32 BACTERIAL COLITIS 1 0.0056
33 DEPENDENT PERSONALITY DISORDER 1 0.0055
34 SINGLE UMBILICAL ARTERY 2 0.0054
35 APPLICATION SITE DERMATITIS 5 0.0053
36 ANENCEPHALY 3 0.0053
37 ILEITIS 2 0.0052
38 APPLICATION SITE DISCOLOURATION 21 0.0052
39 FRACTURE MALUNION 1 0.0052
40 ACNE FULMINANS 1 0.0051
41 MEDICAL DIET 1 0.0051
42 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 1 0.0048
43 AUTOINFLAMMATORY DISEASE 1 0.0047
44 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0047
45 CHEMICAL BURN 5 0.0043
46 CERVICAL CYST 1 0.0042
47 APPLICATION SITE DRYNESS 14 0.0041
48 GRANULOMATOUS DERMATITIS 1 0.0041
49 KERATOSIS PILARIS 1 0.0040
50 TRANSVERSE SINUS THROMBOSIS 2 0.0038
51 CHEMICAL INJURY 3 0.0037
52 CAPILLARITIS 1 0.0036
53 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
54 COMPLICATION OF DELIVERY 1 0.0035
55 ALOPECIA UNIVERSALIS 1 0.0034
56 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
57 BED REST 1 0.0032
58 BREAST CELLULITIS 1 0.0032
59 SKIN TEXTURE ABNORMAL 3 0.0031
60 DERMOID CYST 1 0.0030
61 LARYNGOMALACIA 1 0.0030
62 MASS EXCISION 1 0.0029
63 GAIT SPASTIC 1 0.0029
64 NEUROMUSCULAR TOXICITY 1 0.0028
65 PNEUMOMEDIASTINUM 5 0.0028
66 IMPLANT SITE DISCHARGE 1 0.0027
67 BREAST RECONSTRUCTION 1 0.0027
68 CAPILLARY DISORDER 1 0.0026
69 BLIGHTED OVUM 1 0.0025
70 ANAL HAEMORRHAGE 7 0.0025
71 LICHENIFICATION 1 0.0024
72 XEROSIS 3 0.0024
73 TWIN PREGNANCY 2 0.0024
74 FRACTURE DISPLACEMENT 1 0.0023
75 MOUTH BREATHING 1 0.0023
76 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
77 ALLERGY TO PLANTS 1 0.0022
78 ECZEMA HERPETICUM 1 0.0022
79 EHLERS-DANLOS SYNDROME 1 0.0022
80 CHLOASMA 1 0.0022
81 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
82 GASTRIC VARICES 1 0.0021
83 METAPLASIA 1 0.0021
84 HEPATIC HAEMATOMA 1 0.0021
85 APPLICATION SITE ACNE 1 0.0020
86 HYPERMOBILITY SYNDROME 1 0.0020
87 IMPLANT SITE SWELLING 2 0.0020
88 CAPILLARY FRAGILITY 1 0.0020
89 NEONATAL DISORDER 3 0.0019
90 APPLICATION SITE PAPULES 2 0.0019
91 ANAL STENOSIS 1 0.0019
92 AUTOSCOPY 1 0.0019
93 EPHELIDES 1 0.0019
94 SKIN WRINKLING 5 0.0018
95 INTERTRIGO 1 0.0018
96 GENITAL DISCOMFORT 1 0.0018
97 PERIRECTAL ABSCESS 2 0.0018
98 DYSPRAXIA 1 0.0018
99 BILIARY DYSKINESIA 3 0.0018
100 APPLICATION SITE ERYTHEMA 46 0.0018
101 LUMBAR RADICULOPATHY 2 0.0017
102 APPLICATION SITE PAIN 38 0.0017
103 AORTIC CALCIFICATION 1 0.0017
104 ADENOMYOSIS 1 0.0017
105 INDUCED LABOUR 1 0.0017
106 ANTEROGRADE AMNESIA 1 0.0017
107 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
108 AURICULAR SWELLING 1 0.0017
109 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
110 APPLICATION SITE BURN 8 0.0016
111 PREGNANCY 32 0.0016
112 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
113 CYANOSIS NEONATAL 1 0.0016
114 MITRAL VALVE CALCIFICATION 1 0.0016
115 NEUROPATHIC ARTHROPATHY 1 0.0015
116 JOB DISSATISFACTION 1 0.0015
117 CELLULITIS STAPHYLOCOCCAL 1 0.0015
118 APPLICATION SITE PARAESTHESIA 2 0.0015
119 BROW PTOSIS 1 0.0015
120 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
121 INJECTION SITE EXFOLIATION 1 0.0015
122 MACULAR FIBROSIS 1 0.0015
123 LICHEN SCLEROSUS 1 0.0015
124 ANGULAR CHEILITIS 1 0.0014
125 APPLICATION SITE INFLAMMATION 2 0.0014
126 DEATH NEONATAL 2 0.0014
127 INFLAMMATORY BOWEL DISEASE 14 0.0014
128 APPLICATION SITE SWELLING 7 0.0014
129 LIP PAIN 4 0.0014
130 BRONCHIAL WALL THICKENING 1 0.0014
131 BITE 1 0.0014
132 HODGKIN'S DISEASE 1 0.0014
133 BLOOD FOLATE DECREASED 1 0.0014
134 ATROPHIC VULVOVAGINITIS 1 0.0014
135 FIBROCYSTIC BREAST DISEASE 1 0.0014
136 IMPLANT SITE BRUISING 1 0.0013
137 APPLICATION SITE URTICARIA 3 0.0013
138 GINGIVAL ULCERATION 1 0.0013
139 ACNE CYSTIC 4 0.0013
140 ADHESION 2 0.0013
141 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
142 LIMB ASYMMETRY 1 0.0013
143 HYPERTRANSAMINASAEMIA 9 0.0013
144 LABORATORY TEST INTERFERENCE 1 0.0013
145 AORTIC DISORDER 1 0.0013
146 BREAST CALCIFICATIONS 1 0.0013
147 MAMMOPLASTY 1 0.0013
148 CARTILAGE ATROPHY 1 0.0012
149 RESPIRATORY ALKALOSIS 2 0.0012
150 FEAR OF FALLING 1 0.0012
151 GUTTATE PSORIASIS 1 0.0012
152 BOTULISM 1 0.0012
153 APPLICATION SITE IRRITATION 15 0.0012
154 CAMPYLOBACTER INFECTION 1 0.0012
155 COVID-19 IMMUNISATION 1 0.0012
156 LUNG HYPERINFLATION 1 0.0012
157 SKIN HYPERPIGMENTATION 10 0.0012
158 LIPOMA 3 0.0012
159 GINGIVAL ERYTHEMA 1 0.0012
160 BURNS SECOND DEGREE 2 0.0011
161 LARGE FOR DATES BABY 1 0.0011
162 SKIN HYPOPIGMENTATION 2 0.0011
163 NUCHAL RIGIDITY 1 0.0011
164 APPLICATION SITE VESICLES 7 0.0011
165 BONE CYST 1 0.0011
166 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0011
167 SKIN TIGHTNESS 5 0.0011
168 GALLBLADDER INJURY 2 0.0010
169 LYMPHADENECTOMY 1 0.0010
170 COLON ADENOMA 1 0.0010
171 HAEMANGIOMA OF LIVER 1 0.0010
172 LIP DRY 9 0.0010
173 HYPOGONADISM 1 0.0010
174 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
175 EYE COLOUR CHANGE 1 0.0010
176 IMPLANT SITE ERYTHEMA 1 0.0010
177 INFUSION SITE DISCOMFORT 1 0.0010
178 JOINT SPRAIN 1 0.0010
179 FEEDING DISORDER NEONATAL 1 0.0010
180 SLEEP DEFICIT 2 0.0009
181 INNER EAR DISORDER 1 0.0009
182 BLADDER DILATATION 1 0.0009
183 SKIN EXFOLIATION 77 0.0009
184 MELANOCYTIC NAEVUS 4 0.0009
185 CORNEAL DISORDER 2 0.0009
186 AORTIC DILATATION 1 0.0009
187 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
188 CHOLECYSTITIS CHRONIC 6 0.0009
189 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
190 LIGAMENT INJURY 1 0.0009
191 BLADDER OPERATION 1 0.0009
192 INCISION SITE PAIN 1 0.0009
193 GROIN ABSCESS 1 0.0008
194 BRONCHIAL HYPERREACTIVITY 1 0.0008
195 FEBRILE CONVULSION 1 0.0008
196 SEBORRHOEA 3 0.0008
197 DERMAL CYST 2 0.0008
198 EXPIRED DRUG ADMINISTERED 4 0.0008
199 BLOOD UREA DECREASED 1 0.0008
200 FRACTURED SACRUM 1 0.0008
201 SKIN INFECTION 9 0.0008
202 EYELID IRRITATION 2 0.0008
203 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
204 BRADYCARDIA NEONATAL 1 0.0008
205 BREECH PRESENTATION 1 0.0008
206 LEFT ATRIAL DILATATION 1 0.0008
207 LIP HAEMORRHAGE 1 0.0008
208 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
209 SKIN DISCOMFORT 2 0.0007
210 CHEILITIS 4 0.0007
211 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
212 MENINGITIS VIRAL 1 0.0007
213 CROHN'S DISEASE 5 0.0007
214 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
215 INCISIONAL HERNIA 1 0.0007
216 JOINT INSTABILITY 1 0.0007
217 PROCTITIS 2 0.0007
218 DERMATITIS CONTACT 8 0.0007
219 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
220 SKIN IRRITATION 32 0.0007
221 HEPATIC LESION 3 0.0007
222 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
223 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
224 IMMUNOSUPPRESSION 6 0.0007
225 IMPETIGO 1 0.0007
226 APPLICATION SITE RASH 9 0.0007
227 ROSACEA 3 0.0006
228 SKIN ABRASION 3 0.0006
229 POLYMYALGIA RHEUMATICA 2 0.0006
230 INTESTINAL ULCER 1 0.0006
231 INTRA-UTERINE DEATH 1 0.0006
232 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
233 SKIN EROSION 2 0.0006
234 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
235 METABOLIC SYNDROME 1 0.0006
236 HYPERAESTHESIA 5 0.0006
237 INTESTINAL POLYP 1 0.0006
238 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
239 EDUCATIONAL PROBLEM 1 0.0006
240 CAESAREAN SECTION 7 0.0006
241 EXPOSURE TO SARS-COV-2 1 0.0006
242 LAZINESS 1 0.0006
243 SCAR 10 0.0006
244 MASTECTOMY 1 0.0006
245 BREAST DISCHARGE 1 0.0006
246 INFUSION SITE DISCHARGE 1 0.0006
247 ACNE 43 0.0006
248 KYPHOSIS 1 0.0006
249 JUGULAR VEIN THROMBOSIS 1 0.0006
250 FACIAL PAIN 5 0.0006
251 ANAL FISSURE 3 0.0006
252 ERYTHEMA OF EYELID 3 0.0006
253 CALCIPHYLAXIS 1 0.0005
254 HYPERKERATOSIS 3 0.0005
255 TENDON INJURY 2 0.0005
256 LYMPH NODE PAIN 1 0.0005
257 SUNBURN 4 0.0005
258 BLADDER SPASM 1 0.0005
259 PREMATURE LABOUR 3 0.0005
260 NARCOLEPSY 1 0.0005
261 CHOLECYSTITIS ACUTE 3 0.0005
262 INFECTED SKIN ULCER 1 0.0005
263 SCAB 6 0.0005
264 HYPERCOAGULATION 1 0.0005
265 HYPOREFLEXIA 1 0.0005
266 SKIN ATROPHY 3 0.0005
267 HEPATIC MASS 1 0.0005
268 ATROPHY 1 0.0005
269 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
270 NAIL DISCOLOURATION 2 0.0005
271 SINUS HEADACHE 3 0.0005
272 PATENT DUCTUS ARTERIOSUS 2 0.0005
273 LIPIDS INCREASED 1 0.0005
274 EAR HAEMORRHAGE 1 0.0005
275 DERMATITIS ACNEIFORM 3 0.0005
276 EYELID PAIN 1 0.0005
277 APPLICATION SITE PRURITUS 11 0.0005
278 PRODUCT ODOUR ABNORMAL 5 0.0005
279 DEVICE MATERIAL ISSUE 1 0.0005
280 NEUROGENIC BLADDER 1 0.0005
281 EYE CONTUSION 1 0.0005
282 EAR SWELLING 1 0.0005
283 SKIN HAEMORRHAGE 7 0.0005
284 LIPODYSTROPHY ACQUIRED 1 0.0005
285 ABNORMAL SENSATION IN EYE 2 0.0005
286 CHAPPED LIPS 2 0.0005
287 ONYCHOMYCOSIS 2 0.0005
288 SPINAL OSTEOARTHRITIS 4 0.0005
289 ADENOCARCINOMA 1 0.0004
290 FEAR OF DEATH 1 0.0004
291 BURNING SENSATION 31 0.0004
292 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
293 FEELING OF DESPAIR 2 0.0004
294 THERMAL BURN 3 0.0004
295 PRE-ECLAMPSIA 2 0.0004
296 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
297 SKIN FISSURES 8 0.0004
298 DENTAL OPERATION 1 0.0004
299 SKIN LESION 11 0.0004
300 ERYTHEMA 82 0.0004
301 CHEMICAL BURN OF SKIN 1 0.0004
302 EXCORIATION 1 0.0004
303 PATHOLOGICAL FRACTURE 2 0.0004
304 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
305 ABNORMAL UTERINE BLEEDING 1 0.0004
306 MEAN CELL VOLUME INCREASED 1 0.0004
307 MENOPAUSE 1 0.0004
308 BLOOD CHLORIDE DECREASED 1 0.0004
309 DRUG TITRATION ERROR 1 0.0004
310 ACTINIC KERATOSIS 1 0.0004
311 BLOOD POTASSIUM ABNORMAL 1 0.0004
312 ANAL FISTULA 2 0.0004
313 GASTROINTESTINAL INJURY 1 0.0004
314 PSORIATIC ARTHROPATHY 15 0.0004
315 CHONDROPATHY 1 0.0004
316 ABDOMINAL RIGIDITY 1 0.0004
317 LARGE INTESTINAL ULCER 1 0.0004
318 ANORGASMIA 1 0.0004
319 CLUMSINESS 1 0.0004
320 SKIN BURNING SENSATION 26 0.0004
321 IMMUNE-MEDIATED MYOSITIS 1 0.0004
322 INTRACRANIAL PRESSURE INCREASED 2 0.0004
323 APHONIA 5 0.0004
324 ELECTRIC SHOCK SENSATION 1 0.0004
325 JOINT LOCK 1 0.0004
326 PRODUCT CONTAINER ISSUE 3 0.0003
327 VENTRICULAR SEPTAL DEFECT 2 0.0003
328 VISUAL DISTURBANCE 2 0.0003
329 EYELID OEDEMA 4 0.0003
330 PRODUCT LABEL CONFUSION 2 0.0003
331 LUMBAR SPINAL STENOSIS 1 0.0003
332 HYPERTRIGLYCERIDAEMIA 2 0.0003
333 NECK INJURY 1 0.0003
334 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
335 CENTRAL VENOUS CATHETERISATION 1 0.0003
336 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
337 EMBOLISM VENOUS 1 0.0003
338 DRY SKIN 44 0.0003
339 INGUINAL HERNIA 2 0.0003
340 MEDICAL DEVICE DISCOMFORT 1 0.0003
341 IRRITABLE BOWEL SYNDROME 7 0.0003
342 CHEST X-RAY ABNORMAL 1 0.0003
343 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
344 LARYNGEAL OEDEMA 2 0.0003
345 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
346 PIGMENTATION DISORDER 2 0.0003
347 EYE SWELLING 12 0.0003
348 BASAL CELL CARCINOMA 5 0.0003
349 PRE-EXISTING CONDITION IMPROVED 2 0.0003
350 BLOOD CREATININE DECREASED 1 0.0003
351 LACERATION 3 0.0003
352 ARTERIOSCLEROSIS 3 0.0003
353 ABORTION INDUCED 3 0.0003
354 EOSINOPHILIC PNEUMONIA 1 0.0003
355 NON-CARDIAC CHEST PAIN 1 0.0003
356 PNEUMOTHORAX 5 0.0003
357 RASH MACULAR 11 0.0003
358 PSORIASIS 41 0.0003
359 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
360 CUSHINGOID 1 0.0003
361 LOOSE TOOTH 1 0.0003
362 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
363 SKIN DISCOLOURATION 14 0.0003
364 INFUSION SITE HAEMORRHAGE 1 0.0003
365 LIGAMENT SPRAIN 3 0.0003
366 PRODUCT FORMULATION ISSUE 2 0.0003
367 ABORTION SPONTANEOUS 12 0.0003
368 BREAST MASS 2 0.0003
369 EYELID PTOSIS 3 0.0003
370 IMPAIRED GASTRIC EMPTYING 4 0.0003
371 BLOOD TESTOSTERONE DECREASED 2 0.0003
372 LOCAL SWELLING 5 0.0003
373 DERMATITIS 6 0.0003
374 CAROTID ARTERY STENOSIS 1 0.0003
375 EAR PRURITUS 1 0.0003
376 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
377 SCRATCH 3 0.0003
378 APPLICATION SITE REACTION 2 0.0003
379 SKIN REACTION 4 0.0003
380 LOGORRHOEA 1 0.0003
381 BONE EROSION 1 0.0003
382 MACULOPATHY 1 0.0003
383 FIBRIN D DIMER INCREASED 1 0.0003
384 THERAPEUTIC RESPONSE DECREASED 17 0.0003
385 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
386 IMPAIRED QUALITY OF LIFE 4 0.0003
387 FACIAL BONES FRACTURE 1 0.0003
388 TREATMENT FAILURE 23 0.0003
389 INJECTION SITE NODULE 3 0.0003
390 TOOTH FRACTURE 3 0.0003
391 SKIN ULCER 7 0.0003
392 HYPERACUSIS 1 0.0003
393 REBOUND EFFECT 3 0.0003
394 MITRAL VALVE INCOMPETENCE 3 0.0003
395 AUTOIMMUNE THYROIDITIS 1 0.0003
396 FACE INJURY 1 0.0003
397 MICTURITION URGENCY 3 0.0003
398 INSURANCE ISSUE 4 0.0003
399 COMMUNICATION DISORDER 1 0.0003
400 BOWEL MOVEMENT IRREGULARITY 2 0.0003
401 ACUTE RESPIRATORY FAILURE 5 0.0003
402 FOOD ALLERGY 2 0.0003
403 EAR PAIN 5 0.0003
404 THERAPY PARTIAL RESPONDER 4 0.0003
405 FURUNCLE 2 0.0003
406 CHOLECYSTITIS 3 0.0003
407 HYPERLIPIDAEMIA 3 0.0003
408 SCIATICA 4 0.0003
409 CEREBRAL ATROPHY 1 0.0003
410 BLEPHARITIS 1 0.0002
411 ENURESIS 1 0.0002
412 COLITIS ULCERATIVE 11 0.0002
413 GOITRE 1 0.0002
414 PHARYNGITIS 3 0.0002
415 CYST 3 0.0002
416 AORTIC DISSECTION 1 0.0002
417 ILEUS 3 0.0002
418 CONGESTIVE CARDIOMYOPATHY 1 0.0002
419 SKIN DISORDER 8 0.0002
420 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
421 SKIN PLAQUE 2 0.0002
422 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
423 AORTIC VALVE INCOMPETENCE 1 0.0002
424 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
425 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
426 METASTATIC NEOPLASM 1 0.0002
427 HYSTERECTOMY 2 0.0002
428 OCULAR ICTERUS 1 0.0002
429 SKIN SWELLING 2 0.0002
430 RASH ERYTHEMATOUS 11 0.0002
431 NAIL DISORDER 2 0.0002
432 DYSPHEMIA 1 0.0002
433 PURPURA 2 0.0002
434 CATHETERISATION CARDIAC 1 0.0002
435 GALLBLADDER DISORDER 4 0.0002
436 PAIN OF SKIN 6 0.0002
437 HIDRADENITIS 2 0.0002
438 GASTRITIS EROSIVE 1 0.0002
439 APPENDICITIS 2 0.0002
440 INJURY 15 0.0002
441 EXPIRED PRODUCT ADMINISTERED 7 0.0002
442 LIP SWELLING 7 0.0002
443 GESTATIONAL DIABETES 1 0.0002
444 ENDOMETRIOSIS 1 0.0002
445 HYPOVOLAEMIC SHOCK 1 0.0002
446 ATELECTASIS 2 0.0002
447 VITAMIN D DEFICIENCY 2 0.0002
448 HORMONE LEVEL ABNORMAL 1 0.0002
449 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
450 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
451 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
452 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
453 INJECTION SITE INFLAMMATION 1 0.0002
454 PRODUCT PHYSICAL ISSUE 4 0.0002
455 OSTEOPENIA 3 0.0002
456 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
457 AMMONIA INCREASED 1 0.0002
458 BLISTER 11 0.0002
459 INJECTION SITE DISCOMFORT 2 0.0002
460 RESPIRATORY TRACT CONGESTION 3 0.0002
461 OSTEOARTHRITIS 8 0.0002
462 ANORECTAL DISCOMFORT 1 0.0002
463 FOOD POISONING 1 0.0002
464 DEEP VEIN THROMBOSIS 12 0.0002
465 COLITIS 7 0.0002
466 SWELLING FACE 12 0.0002
467 GASTROINTESTINAL PAIN 2 0.0002
468 PHOTOSENSITIVITY REACTION 3 0.0002
469 DEAFNESS UNILATERAL 1 0.0002
470 DENTAL CARIES 2 0.0002
471 EYE PRURITUS 6 0.0002
472 RASH PAPULAR 4 0.0002
473 MACULAR OEDEMA 1 0.0002
474 OCULAR DISCOMFORT 2 0.0002
475 EYE PAIN 10 0.0002
476 IMPAIRED DRIVING ABILITY 2 0.0002
477 NEUROLOGICAL SYMPTOM 1 0.0002
478 CORONARY ARTERY BYPASS 1 0.0002
479 EXERCISE TOLERANCE DECREASED 1 0.0002
480 MOUTH SWELLING 1 0.0002
481 ENERGY INCREASED 1 0.0002
482 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
483 URINARY INCONTINENCE 5 0.0002
484 MACULAR DEGENERATION 2 0.0002
485 OSTEOMYELITIS 3 0.0002
486 RESTLESS LEGS SYNDROME 3 0.0002
487 NOCTURIA 2 0.0002
488 PRURITUS 63 0.0002
489 MENISCUS INJURY 1 0.0002
490 CONJUNCTIVITIS 3 0.0002
491 INFUSION SITE EXTRAVASATION 1 0.0002
492 INJECTION SITE DISCOLOURATION 2 0.0002
493 NASAL DRYNESS 1 0.0002
494 INFUSION SITE SWELLING 1 0.0002
495 BLEPHAROSPASM 1 0.0002
496 MULTIPLE INJURIES 1 0.0002
497 INJECTION SITE IRRITATION 2 0.0002
498 MOOD SWINGS 5 0.0002
499 ENTERITIS 1 0.0002
500 HYPERSENSITIVITY 29 0.0002
501 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
502 GLAUCOMA 3 0.0002
503 ERECTILE DYSFUNCTION 4 0.0002
504 THERAPY NON-RESPONDER 7 0.0002
505 HIATUS HERNIA 2 0.0002
506 PLATELET COUNT INCREASED 2 0.0002
507 NASAL CONGESTION 9 0.0002
508 MENORRHAGIA 3 0.0002
509 ANHEDONIA 4 0.0002
510 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
511 ADVERSE REACTION 2 0.0002
512 BRONCHIECTASIS 1 0.0001
513 COLITIS ISCHAEMIC 1 0.0001
514 ABNORMAL LOSS OF WEIGHT 1 0.0001
515 INFARCTION 1 0.0001
516 ECCHYMOSIS 1 0.0001
517 RASH 63 0.0001
518 LARGE INTESTINE POLYP 1 0.0001
519 LARGE INTESTINE PERFORATION 1 0.0001
520 ARTHROPATHY 8 0.0001
521 AUTOIMMUNE HEPATITIS 1 0.0001
522 FORMICATION 1 0.0001
523 ROAD TRAFFIC ACCIDENT 6 0.0001
524 NECK PAIN 8 0.0001
525 CARPAL TUNNEL SYNDROME 2 0.0001
526 BLOOD TEST ABNORMAL 2 0.0001
527 LYMPHOPENIA 2 0.0001
528 SEASONAL ALLERGY 2 0.0001
529 LYMPHADENOPATHY 5 0.0001
530 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
531 DIVERTICULUM 1 0.0001
532 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
533 METASTASIS 1 0.0001
534 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
535 ANOSMIA 2 0.0001
536 INJECTION SITE HAEMATOMA 2 0.0001
537 PRODUCT PRESCRIBING ISSUE 3 0.0001
538 URTICARIA 23 0.0001
539 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
540 PULMONARY EMBOLISM 13 0.0001
541 DYSURIA 5 0.0001
542 INFLAMMATION 7 0.0001
543 IMMUNODEFICIENCY 2 0.0001
544 ECZEMA 7 0.0001
545 SNEEZING 3 0.0001
546 BREAST TENDERNESS 1 0.0001
547 INTESTINAL OBSTRUCTION 5 0.0001
548 EMOTIONAL DISTRESS 16 0.0001
549 CORONARY ARTERY DISEASE 4 0.0001
550 HEPATOCELLULAR CARCINOMA 1 0.0001
551 PLEURAL EFFUSION 8 0.0001
552 AORTIC ANEURYSM 1 0.0001
553 NEPHROLITHIASIS 6 0.0001
554 THYROID DISORDER 2 0.0001
555 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
556 CONCUSSION 1 0.0001
557 BLOOD CHOLESTEROL INCREASED 6 0.0001
558 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
559 OCULAR HYPERAEMIA 6 0.0001
560 PRODUCT PRESCRIBING ERROR 3 0.0001
561 SENSORY DISTURBANCE 2 0.0001
562 MYASTHENIA GRAVIS 1 0.0001
563 ABNORMAL FAECES 1 0.0001
564 CHOLELITHIASIS 4 0.0001
565 MANIA 2 0.0001
566 ABASIA 3 0.0001
567 HAIR DISORDER 1 0.0001
568 MENSTRUAL DISORDER 1 0.0001
569 HEMIPLEGIA 1 0.0001
570 EOSINOPHIL COUNT INCREASED 1 0.0001
571 POLLAKIURIA 5 0.0001
572 ATRIAL SEPTAL DEFECT 1 0.0001
573 SURGERY 7 0.0001
574 INFUSION SITE ERYTHEMA 1 0.0001
575 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
576 PRODUCT COMPLAINT 3 0.0001
577 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
578 ILLNESS 12 0.0001
579 MUSCULOSKELETAL DISCOMFORT 2 0.0001
580 RASH GENERALISED 3 0.0001
581 DIPLOPIA 3 0.0001
582 DEVICE DEFECTIVE 2 0.0001
583 DISCOMFORT 7 0.0001
584 AMENORRHOEA 2 0.0001
585 BLOOD CALCIUM INCREASED 1 0.0001
586 HEAD DISCOMFORT 2 0.0001
587 DRUG ERUPTION 2 0.0001
588 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
589 HAEMOLYTIC ANAEMIA 1 0.0001
590 THROAT IRRITATION 5 0.0001
591 LOSS OF LIBIDO 1 0.0001
592 FREQUENT BOWEL MOVEMENTS 3 0.0001
593 COMPLICATION OF DEVICE REMOVAL 2 0.0001
594 TOOTHACHE 2 0.0001
595 LIMB INJURY 3 0.0001
596 MOOD ALTERED 3 0.0001
597 EXOSTOSIS 1 0.0001
598 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
599 PAIN 67 0.0001
600 TINNITUS 5 0.0001
601 NERVE COMPRESSION 1 0.0001
602 PROCEDURAL PAIN 3 0.0001
603 SINUSITIS 11 0.0001
604 HEPATIC ENCEPHALOPATHY 1 0.0001
605 MIDDLE INSOMNIA 2 0.0001
606 DEFORMITY 1 0.0001
607 BLOOD SODIUM DECREASED 2 0.0001
608 EYE INFLAMMATION 1 0.0001
609 SLEEP APNOEA SYNDROME 2 0.0001
610 EYE IRRITATION 6 0.0001
611 POST PROCEDURAL COMPLICATION 2 0.0001
612 AFFECT LABILITY 1 0.0001
613 AUTOIMMUNE DISORDER 1 0.0001
614 HAEMORRHOIDS 2 0.0001
615 LUNG DISORDER 5 0.0001
616 HOSPICE CARE 1 0.0001
617 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
618 EMBEDDED DEVICE 1 0.0001
619 DRY EYE 5 0.0001
620 BRAIN INJURY 1 0.0001
621 PREMATURE BABY 3 0.0001
622 EMPHYSEMA 1 0.0001
623 DRY THROAT 1 0.0001
624 MOTOR DYSFUNCTION 1 0.0001
625 FEELING HOT 6 0.0001
626 EAR DISCOMFORT 1 0.0001
627 OROPHARYNGEAL PAIN 9 0.0001
628 TOOTH LOSS 2 0.0001
629 EYE DISCHARGE 1 0.0001
630 FOLLICULITIS 1 0.0001
631 DERMATITIS ATOPIC 5 0.0001
632 ABDOMINAL PAIN 22 0.0001
633 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
634 EATING DISORDER 2 0.0001
635 HYPERHIDROSIS 12 0.0001
636 POOR QUALITY SLEEP 2 0.0001
637 SKIN CANCER 2 0.0001
638 DRUG EFFECT DECREASED 5 0.0001
639 PRURITUS GENERALISED 2 0.0001
640 DEPRESSION 21 0.0001
641 CHRONIC KIDNEY DISEASE 7 0.0001
642 DEVICE DISLOCATION 4 0.0001
643 TREATMENT NONCOMPLIANCE 5 0.0001
644 EYE DISORDER 3 0.0001
645 STAPHYLOCOCCAL INFECTION 3 0.0001
646 FOOT DEFORMITY 1 0.0001
647 OFF LABEL USE 79 0.0001
648 VIRAL INFECTION 3 0.0001
649 FUNGAL INFECTION 3 0.0001
650 NERVE INJURY 1 0.0001
651 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
652 INJECTION SITE PRURITUS 6 0.0001
653 MALNUTRITION 1 0.0001
654 HEADACHE 56 0.0001
655 ARTHRITIS 7 0.0001
656 ANGER 3 0.0001
657 EYE INFECTION 1 0.0001
658 ANXIETY 25 0.0001
659 HAEMATURIA 3 0.0001
660 CHOLECYSTECTOMY 1 0.0001
661 SUICIDAL IDEATION 8 0.0001
662 LETHARGY 5 0.0001
663 MADAROSIS 1 0.0001
664 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
665 BLOOD IRON DECREASED 1 0.0001
666 ATAXIA 1 0.0001
667 DRUG INEFFECTIVE 110 0.0001
668 BLOOD PRESSURE FLUCTUATION 2 0.0001
669 IRRITABILITY 5 0.0001
670 HEPATITIS C 1 0.0001
671 DRUG EFFECT INCOMPLETE 3 0.0001
672 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
673 CRYING 3 0.0001
674 NEURALGIA 2 0.0001
675 CONDITION AGGRAVATED 25 0.0001
676 ALOPECIA 16 0.0001
677 PRODUCT QUALITY ISSUE 11 0.0001
678 HAIR COLOUR CHANGES 1 0.0001
679 AGEUSIA 2 0.0001
680 CELLULITIS 4 0.0001
681 BRAIN OEDEMA 1 0.0001
682 ABDOMINAL PAIN LOWER 2 0.0001
683 MUSCLE ATROPHY 1 0.0001
684 DRUG DOSE OMISSION 13 0.0001
685 MYDRIASIS 1 0.0001
686 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
687 GENITAL HAEMORRHAGE 1 0.0001
688 ANOREXIA 1 0.0001
689 INJECTION SITE INDURATION 1 0.0001
690 NODULE 1 0.0001
691 PARAESTHESIA 12 0.0001
692 INCORRECT PRODUCT STORAGE 1 0.0001
693 BEDRIDDEN 1 0.0001
694 GASTRITIS 2 0.0001
695 NASOPHARYNGITIS 14 0.0001
696 IMMUNE SYSTEM DISORDER 1 0.0001
697 ANKYLOSING SPONDYLITIS 1 0.0001
698 DYSMENORRHOEA 1 0.0001
699 INJECTION SITE HAEMORRHAGE 6 0.0001
700 HAIR TEXTURE ABNORMAL 1 0.0001
701 JOINT RANGE OF MOTION DECREASED 1 0.0001
702 FEAR 2 0.0001
703 BLOOD BILIRUBIN INCREASED 2 0.0001
704 RASH PRURITIC 4 0.0001
705 CORONARY ARTERY OCCLUSION 1 0.0001
706 INJECTION SITE ERYTHEMA 9 0.0001
707 HAEMATOCHEZIA 4 0.0001
708 RESPIRATORY DISTRESS 2 0.0001
709 FEELING COLD 2 0.0001
710 HUNGER 1 0.0001
711 COORDINATION ABNORMAL 1 0.0001
712 SOMNOLENCE 14 0.0001
713 MYELODYSPLASTIC SYNDROME 1 0.0001
714 VAGINAL HAEMORRHAGE 3 0.0001
715 GASTROENTERITIS 1 0.0001
716 DYSPHONIA 4 0.0001
717 BRONCHITIS 5 0.0001
718 ARTHRALGIA 28 0.0001
719 COLON CANCER 1 0.0001
720 RESPIRATORY DISORDER 2 0.0001
721 APHASIA 2 0.0001
722 LACRIMATION INCREASED 2 0.0001
723 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
724 ECONOMIC PROBLEM 1 0.0001
725 BLOOD COUNT ABNORMAL 1 0.0001
726 DEVICE FAILURE 1 0.0001
727 INJECTION SITE SWELLING 5 0.0001
728 DRUG ADMINISTRATION ERROR 2 0.0001
729 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
730 EMOTIONAL DISORDER 2 0.0001
731 LYMPHOMA 1 0.0001
732 GYNAECOMASTIA 2 0.0001
733 ANKLE FRACTURE 1 0.0001
734 BACK PAIN 15 0.0001
735 DELUSION 1 0.0001
736 LUNG INFECTION 1 0.0001
737 COGNITIVE DISORDER 3 0.0001
738 SWELLING 6 0.0001
739 BRAIN FOG 1 0.0001
740 HEAD INJURY 2 0.0001
741 ABDOMINAL PAIN UPPER 13 0.0001
742 NEUROPATHY PERIPHERAL 6 0.0001
743 HALLUCINATION, AUDITORY 1 0.0001
744 MIGRAINE 6 0.0001
745 PRODUCTIVE COUGH 3 0.0001
746 CYSTITIS 2 0.0001
747 INFLUENZA 7 0.0001
748 OBESITY 1 0.0001
749 ABSCESS 1 0.0001
750 HYPOTHYROIDISM 2 0.0001
751 CONTUSION 6 0.0001
752 NIGHT SWEATS 2 0.0001
753 INTERSTITIAL LUNG DISEASE 3 0.0001
754 RHINORRHOEA 4 0.0001
755 BACK DISORDER 1 0.0001
756 IMPAIRED HEALING 2 0.0001
757 COUGH 17 0.0001
758 DIARRHOEA 39 0.0001
759 VISUAL ACUITY REDUCED 2 0.0001
760 COAGULOPATHY 1 0.0001
761 SYNCOPE 6 0.0001
762 BLOOD UREA INCREASED 1 0.0001
763 FACE OEDEMA 1 0.0001
764 CANDIDA INFECTION 1 0.0001
765 THERAPY CESSATION 3 0.0001
766 INJECTION SITE REACTION 4 0.0001
767 PRODUCT DOSE OMISSION ISSUE 17 0.0001
768 NIGHTMARE 2 0.0001
769 VOMITING 27 0.0001
770 SPEECH DISORDER 3 0.0001
771 INTENTIONAL PRODUCT MISUSE 5 0.0001
772 MUSCULOSKELETAL STIFFNESS 5 0.0001
773 COVID-19 10 0.0001
774 DEPRESSED MOOD 3 0.0001
775 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
776 THERAPY INTERRUPTED 4 0.0001
777 GASTROINTESTINAL DISORDER 5 0.0001
778 GOUT 1 0.0001
779 DISTURBANCE IN ATTENTION 3 0.0001
780 OEDEMA 3 0.0001
781 INFECTION 8 0.0001
782 C-REACTIVE PROTEIN INCREASED 2 0.0001
783 BONE DISORDER 1 0.0001
784 HYPOTENSION 11 0.0001
785 INJECTION SITE MASS 2 0.0001
786 WEIGHT DECREASED 15 0.0001
787 BACTERIAL INFECTION 1 0.0001
788 HEPATIC CIRRHOSIS 1 0.0001
789 DYSARTHRIA 2 0.0001
790 DYSPNOEA EXERTIONAL 2 0.0001
791 RHEUMATOID ARTHRITIS 6 0.0001
792 MUSCULAR WEAKNESS 6 0.0001
793 FOOT FRACTURE 1 0.0001
794 GASTRIC ULCER 1 0.0001
795 MUSCULOSKELETAL DISORDER 1 0.0001
796 PNEUMONIA 17 0.0001
797 FEELING JITTERY 1 0.0001
798 CONVULSION 3 0.0001
799 INCREASED APPETITE 1 0.0001
800 GAIT DISTURBANCE 10 0.0001
801 HERPES ZOSTER 3 0.0001
802 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
803 CHOLESTASIS 1 0.0001
804 LOWER LIMB FRACTURE 1 0.0001
805 DRUG PRESCRIBING ERROR 1 0.0001
806 HERNIA 1 0.0001
807 ERUCTATION 1 0.0001
808 DYSTONIA 1 0.0001
809 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
810 CHOKING 1 0.0001
811 BONE PAIN 3 0.0001
812 KIDNEY INFECTION 1 0.0001
813 MEMORY IMPAIRMENT 7 0.0001
814 WHEEZING 3 0.0001
815 HAEMATOCRIT DECREASED 1 0.0001
816 CARDIAC FAILURE CONGESTIVE 4 0.0000
817 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
818 SUICIDE ATTEMPT 3 0.0000
819 STOMATITIS 3 0.0000
820 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
821 FEEDING DISORDER 1 0.0000
822 DRY MOUTH 4 0.0000
823 DYSKINESIA 2 0.0000
824 INJECTION SITE WARMTH 1 0.0000
825 CHEST PAIN 9 0.0000
826 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
827 EXPOSURE DURING PREGNANCY 3 0.0000
828 KNEE ARTHROPLASTY 1 0.0000
829 HYPERTENSION 10 0.0000
830 URINARY TRACT INFECTION 8 0.0000
831 JOINT INJURY 1 0.0000
832 LIVER FUNCTION TEST INCREASED 1 0.0000
833 RECTAL HAEMORRHAGE 2 0.0000
834 BALANCE DISORDER 4 0.0000
835 MENTAL DISORDER 2 0.0000
836 PRODUCT DOSE OMISSION 3 0.0000
837 DYSPNOEA 26 0.0000
838 BLOOD PRESSURE INCREASED 7 0.0000
839 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
840 INFUSION RELATED REACTION 3 0.0000
841 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
842 FALL 15 0.0000
843 INSOMNIA 12 0.0000
844 TACHYCARDIA 4 0.0000
845 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
846 WEIGHT INCREASED 10 0.0000
847 CHROMATURIA 1 0.0000
848 HEART RATE IRREGULAR 1 0.0000
849 NAUSEA 35 0.0000
850 HEPATIC ENZYME INCREASED 3 0.0000
851 MUSCLE TWITCHING 1 0.0000
852 PALPITATIONS 5 0.0000
853 CHILLS 5 0.0000
854 FEELING ABNORMAL 10 0.0000
855 ABDOMINAL DISCOMFORT 7 0.0000
856 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
857 DRUG INTOLERANCE 4 0.0000
858 LOCALISED INFECTION 1 0.0000
859 CEREBROVASCULAR ACCIDENT 7 0.0000
860 MENTAL IMPAIRMENT 1 0.0000
861 MYALGIA 7 0.0000
862 FIBROMYALGIA 1 0.0000
863 FATIGUE 32 0.0000
864 ATRIAL FIBRILLATION 4 0.0000
865 OEDEMA PERIPHERAL 5 0.0000
866 INJECTION SITE URTICARIA 1 0.0000
867 PAIN IN EXTREMITY 12 0.0000
868 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
869 UNEVALUABLE EVENT 3 0.0000
870 DIABETES MELLITUS 3 0.0000
871 FLUID RETENTION 2 0.0000
872 HYPOPHAGIA 1 0.0000
873 CHEST DISCOMFORT 4 0.0000
874 LOSS OF CONSCIOUSNESS 5 0.0000
875 PERIPHERAL SWELLING 6 0.0000
876 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
877 DECREASED APPETITE 9 0.0000
878 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
879 DEAFNESS 1 0.0000
880 JOINT STIFFNESS 1 0.0000
881 EAR INFECTION 1 0.0000
882 BREAST CANCER FEMALE 1 0.0000
883 MENSTRUATION IRREGULAR 1 0.0000
884 THROMBOSIS 3 0.0000
885 PRODUCT USE ISSUE 7 0.0000
886 JAUNDICE 1 0.0000
887 ANAEMIA 7 0.0000
888 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
889 VISION BLURRED 5 0.0000
890 ANAPHYLACTIC REACTION 2 0.0000
891 DIVERTICULITIS 1 0.0000
892 MEDICATION ERROR 2 0.0000
893 INJECTION SITE PAIN 11 0.0000
894 DEMENTIA 1 0.0000
895 RENAL IMPAIRMENT 3 0.0000
896 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
897 ASTHMA 4 0.0000
898 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
899 INTENTIONAL DOSE OMISSION 1 0.0000
900 INCORRECT DOSE ADMINISTERED 8 0.0000
901 ANGINA PECTORIS 1 0.0000
902 HYPERSOMNIA 1 0.0000
903 PRODUCT SUBSTITUTION ISSUE 2 0.0000
904 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
905 LIVER FUNCTION TEST ABNORMAL 1 0.0000
906 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
907 DIZZINESS 17 0.0000
908 CATARACT 2 0.0000
909 HYPOAESTHESIA 5 0.0000
910 JOINT SWELLING 4 0.0000
911 EPILEPSY 1 0.0000
912 INJECTION SITE RASH 1 0.0000
913 ADVERSE EVENT 3 0.0000
914 FEMUR FRACTURE 1 0.0000
915 CONSTIPATION 7 0.0000
916 BONE DENSITY DECREASED 1 0.0000
917 DRUG-INDUCED LIVER INJURY 1 0.0000
918 DYSPHAGIA 3 0.0000
919 METABOLIC ACIDOSIS 1 0.0000
920 HIP FRACTURE 1 0.0000
921 DEVICE EXPULSION 2 0.0000
922 AMNESIA 2 0.0000
923 DYSPEPSIA 3 0.0000
924 RENAL FAILURE 4 0.0000
925 NEOPLASM MALIGNANT 2 0.0000
926 FLUSHING 3 0.0000
927 ASTHENIA 11 0.0000
928 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
929 GASTRIC DISORDER 1 0.0000
930 PYREXIA 10 0.0000
931 ABDOMINAL DISTENSION 3 0.0000
932 HYPERKALAEMIA 1 0.0000
933 HEART RATE DECREASED 1 0.0000
934 HYPOXIA 1 0.0000
935 PLATELET COUNT DECREASED 3 0.0000
936 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
937 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
938 HYPERGLYCAEMIA 1 0.0000
939 ACCIDENTAL OVERDOSE 1 0.0000
940 SEPSIS 3 0.0000
941 EPISTAXIS 2 0.0000
942 HOT FLUSH 2 0.0000
943 DISEASE PROGRESSION 3 0.0000
944 DISORIENTATION 1 0.0000
945 INJECTION SITE BRUISING 2 0.0000
946 CONFUSIONAL STATE 4 0.0000
947 DEVICE BREAKAGE 1 0.0000
948 INFLUENZA LIKE ILLNESS 2 0.0000
949 VISUAL IMPAIRMENT 3 0.0000
950 DEVICE LEAKAGE 1 0.0000
951 MYOCARDIAL INFARCTION 4 0.0000
952 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
953 MALAISE 10 0.0000
954 ANGIOEDEMA 1 0.0000
955 LIVER DISORDER 1 0.0000
956 DEHYDRATION 3 0.0000
957 DEVICE ISSUE 2 0.0000
958 ADVERSE DRUG REACTION 2 0.0000
959 NO ADVERSE EVENT 4 0.0000
960 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
961 HYPOKALAEMIA 1 0.0000
962 CARDIAC DISORDER 2 0.0000
963 BLOOD GLUCOSE INCREASED 4 0.0000
964 ARRHYTHMIA 1 0.0000
965 DISEASE RECURRENCE 1 0.0000
966 MULTIPLE SCLEROSIS 1 0.0000
967 HYPOGLYCAEMIA 1 0.0000
968 HEART RATE INCREASED 2 0.0000
969 ACUTE KIDNEY INJURY 3 0.0000
970 MUSCULOSKELETAL PAIN 1 0.0000
971 FLATULENCE 1 0.0000
972 MUSCLE SPASMS 3 0.0000
973 DEVICE DIFFICULT TO USE 1 0.0000
974 BLOOD PRESSURE DECREASED 1 0.0000
975 DEVICE MALFUNCTION 1 0.0000
976 MOBILITY DECREASED 1 0.0000
977 OVERDOSE 3 0.0000
978 AGITATION 1 0.0000
979 DYSGEUSIA 1 0.0000
980 DRUG INTERACTION 2 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
982 TREMOR 2 0.0000
983 COMPLETED SUICIDE 1 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
985 BREAST CANCER 1 0.0000
986 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
987 HAEMOGLOBIN DECREASED 1 0.0000
988 HAEMORRHAGE 1 0.0000
989 DEATH 6 0.0000